Risk Factors for Ipsilateral Breast Tumor Recurrence in Triple-Negative or HER2-Positive Breast Cancer Patients Who Achieve a Pathologic Complete Response After Neoadjuvant Chemotherapy.
Makoto IshitobiNaoko MatsudaMizuho TazoSayuka NakayamaRyu TokuiTomoko OgawaAtsushi YoshidaYasuyuki KojimaTakashi KuwayamaTakahiro NakayamaHideko YamauchiSeigo NakamuraKoichiro TsugawaNaoki HayashiPublished in: Annals of surgical oncology (2020)
This retrospective study demonstrated that age at diagnosis was independently associated with IBTR-free survival. Special caution is needed when clinical trials analyzing omission of breast surgery after NAC are enrolling younger patients (UMIN-CTR No. UMIN000037067).
Keyphrases
- neoadjuvant chemotherapy
- free survival
- positive breast cancer
- locally advanced
- clinical trial
- end stage renal disease
- lymph node
- ejection fraction
- sentinel lymph node
- newly diagnosed
- minimally invasive
- transcription factor
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- squamous cell carcinoma
- coronary artery bypass
- rectal cancer
- early stage
- coronary artery disease
- acute coronary syndrome
- radiation therapy
- phase ii